Company recalls compounded drug products
PharMEDium Services LLC has recalled 55 lots of compounded drug products due to a lack of sterility assurance, the Food and Drug Administration announced last week. The products were distributed to U.S. hospitals and clinics. Customers with recalled products should immediately quarantine and destroy them, and may report associated adverse reactions or quality problems to the FDA's MedWatch program.
Related News Articles
Headline
The AHA the week of July 8 released its Quality Collective Report, which explores quality, safety and performance improvement strategies and insights from…
Headline
In a new “Safety Speaks” conversation, Harry S. Smith, board chair of Valley Health System and member of the AHA Committee on Governance, discusses how Valley…
Headline
“Safety Speaks” is a new Advancing Health series where hospital and health system leaders share successes from their organizations’ patient safety efforts. In…
Headline
A new issue brief from AHA’s Hospitals Against Violence initiative offers proven strategies and action steps to help hospitals and health systems’ violence…
Headline
AHA urged leaders of the Senate and House Appropriations Subcommittees on Labor, Health and Human Services, and Education to give favorable funding…
Headline
The Department of Justice May 9 announced the formation of a task force focusing on competition concerns in health care. The unit, the Task Force on Health…